The inositol 5-phosphatase SHIP2 regulates endocytic clathrin-coated pit dynamics
Name
Gertler_The inositol.pdf
Size
6.27 MB
Format
Adobe PDF
Checksum (MD5)
12f0897e9a68ca359460803088057d2c
Author(s)
Gertler, Frank
Nakatsu, Fubito
Perera, Rushika M.
Lucast, Louise
Zoncu, Roberto
Domin, Jan
Toomre, Derek
De Camilli, Pietro
Date Issued
August 2010
Journal
The Journal of Cell Biology
Publisher
Rockefeller University Press
Citation
Nakatsu, F., R. M. Perera, L. Lucast, R. Zoncu, J. Domin, F. B. Gertler, D. Toomre, and P. De Camilli. “The inositol 5-phosphatase SHIP2 regulates endocytic clathrin-coated pit dynamics.” The Journal of Cell Biology 190, no. 3 (August 9, 2010): 307-315.
Version
Final published version
Abstract
Phosphatidylinositol (PI) 4,5-bisphosphate (PI(4,5)P[subscript 2]) and its phosphorylated product PI 3,4,5-triphosphate (PI(3,4,5)P[subscript 3]) are two major phosphoinositides concentrated at the plasma membrane. Their levels, which are tightly controlled by kinases, phospholipases, and phosphatases, regulate a variety of cellular functions, including clathrin-mediated endocytosis and receptor signaling. In this study, we show that the inositol 5-phosphatase SHIP2, a negative regulator of PI(3,4,5)P[subscript 3]-dependent signaling, also negatively regulates PI(4,5)P[subscript 2] levels and is concentrated at endocytic clathrin-coated pits (CCPs) via interactions with the scaffold protein intersectin. SHIP2 is recruited early at the pits and dissociates before fission. Both knockdown of SHIP2 expression and acute production of PI(3,4,5)P[subscript 3] shorten CCP lifetime by enhancing the rate of pit maturation, which is consistent with a positive role of both SHIP2 substrates, PI(4,5)P[subscript 2] and PI(3,4,5)P[subscript 3], on coat assembly. Because SHIP2 is a negative regulator of insulin signaling, our findings suggest the importance of the phosphoinositide metabolism at CCPs in the regulation of insulin signal output.
MIT Department
Massachusetts Institute of Technology. Department of Biology
Koch Institute for Integrative Cancer Research at MIT
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1083/jcb.201005018
